Investigation Report on China Remifentanil Market, 2009-2018
Description
As a new generation of opiates, remifentanil (remifentanil hydrochloride) is an ideal intravenous anesthetic with short onset and good controllability. Remifentanil hydrochloride injection is a narcotic used for the maintenance of general anesthesia.
In China, there is still a large space for narcotic market to grow. And fentanyl takes up over 50% i.e. CNY 5 billion of the narcotic market. As remifentanil is addictive, its production and sales is strictly controlled by the Chinese government who regulates that the number of API manufacturers shall not exceed two while the number of prepration makers shall also be limited. Hence the high barrier. The current landscape of Wuhan Humanwell Pharmaceutical Co., Ltd taking the lead might be changed with the entry of China National Medicines Corporation Limited and Jiangsu Nhwa Pharmaceutical Co., Ltd.
According to CRI’s market survey, the sales value of remifentanil in sample hospitals exceeded CNY 200 million in 2014 and CAGR during the period of 2005-2014 surpassed 30%. Currently, remifentanil products available in the Chinese market all come from Wuhan Humanwell Pharmaceutical Co., Ltd and China National Pharmaceutical Industry Corporation Ltd, among which the former had the largest market share of over 99% for sales value in 2014.
With ageing population and increasing incidence of various diseases caused by environmental pollution and lifestyle changes, the number of operation in China will keep rising, so does the demand for remifentanil.
Readers can get at least the following information through this report:
As a new generation of opiates, remifentanil (remifentanil hydrochloride) is an ideal intravenous anesthetic with short onset and good controllability. Remifentanil hydrochloride injection is a narcotic used for the maintenance of general anesthesia.
In China, there is still a large space for narcotic market to grow. And fentanyl takes up over 50% i.e. CNY 5 billion of the narcotic market. As remifentanil is addictive, its production and sales is strictly controlled by the Chinese government who regulates that the number of API manufacturers shall not exceed two while the number of prepration makers shall also be limited. Hence the high barrier. The current landscape of Wuhan Humanwell Pharmaceutical Co., Ltd taking the lead might be changed with the entry of China National Medicines Corporation Limited and Jiangsu Nhwa Pharmaceutical Co., Ltd.
According to CRI’s market survey, the sales value of remifentanil in sample hospitals exceeded CNY 200 million in 2014 and CAGR during the period of 2005-2014 surpassed 30%. Currently, remifentanil products available in the Chinese market all come from Wuhan Humanwell Pharmaceutical Co., Ltd and China National Pharmaceutical Industry Corporation Ltd, among which the former had the largest market share of over 99% for sales value in 2014.
With ageing population and increasing incidence of various diseases caused by environmental pollution and lifestyle changes, the number of operation in China will keep rising, so does the demand for remifentanil.
Readers can get at least the following information through this report:
- market size of remifentanil in China
- competitive landscape of remifentanil market in China
- price of remifentanil made by different enterprises in China
- market outlook of remifentanil in China
- Pharmaceutical Manufacturers
- investors/research institutions interested in Chinese medicine market
- -any interest in Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF REMIFENTANIL
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF REMIFENTANIL IN CHINA
2.1 Patent and Approval Information of Remifentanil in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON REMIFENTANIL SALES IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR REMIFENTANIL MANUFACTURERS IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF REMIFENTANIL IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF REMIFENTANIL IN CHINESE HOSPITALS IN 2014
6.1 Wuhan Humanwell Pharmaceutical Co., Ltd
6.2 China National Pharmaceutical Industry Corporation Ltd
7 MAJOR MANUFACTURERS OF REMIFENTANIL IN CHINESE MARKET, 2010-2014
7.1 Wuhan Humanwell Pharmaceutical Co., Ltd
7.2 China National Pharmaceutical Industry Corporation Ltd
8 MARKET OUTLOOK OF REMIFENTANIL IN CHINA, 2015-2019
8.1Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Approval Information of Remifentanil in China
Chart Remifentanil Sales in China
Chart Sales Value of Remifentanil in China, 2010-2014
Chart Sales Value of Remifentanil in Some Regions in China, 2010-2014
Chart Sales Volume of Remifentanil in China, 2010-2014
Chart Sales Volume of Remifentanil in Some Regions in China, 2010-2014
Chart Sales Value and Market Share of Remifentanil Made by Wuhan Humanwell in China, 2010-2014
Chart Sales Value and Market Share of Remifentanil Made by China National Pharmaceutical Industry Corporation Ltd in China, 2010-2014
Chart Sales Value and Market Share of Remifentanil Injection in China, 2010-2014
Chart Sales Volume and Market Share of Remifentanil Injection in China, 2010-2014
Chart Price of Remifentanil Made by Wuhan Humanwell in Some Chinese Cities in 2014
Chart Price of Remifentanil Made by China National Pharmaceutical Industry Corporation Ltd in Some Chinese Cities in 2014
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF REMIFENTANIL IN CHINA
2.1 Patent and Approval Information of Remifentanil in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON REMIFENTANIL SALES IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR REMIFENTANIL MANUFACTURERS IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF REMIFENTANIL IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF REMIFENTANIL IN CHINESE HOSPITALS IN 2014
6.1 Wuhan Humanwell Pharmaceutical Co., Ltd
6.2 China National Pharmaceutical Industry Corporation Ltd
7 MAJOR MANUFACTURERS OF REMIFENTANIL IN CHINESE MARKET, 2010-2014
7.1 Wuhan Humanwell Pharmaceutical Co., Ltd
7.2 China National Pharmaceutical Industry Corporation Ltd
8 MARKET OUTLOOK OF REMIFENTANIL IN CHINA, 2015-2019
8.1Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Approval Information of Remifentanil in China
Chart Remifentanil Sales in China
Chart Sales Value of Remifentanil in China, 2010-2014
Chart Sales Value of Remifentanil in Some Regions in China, 2010-2014
Chart Sales Volume of Remifentanil in China, 2010-2014
Chart Sales Volume of Remifentanil in Some Regions in China, 2010-2014
Chart Sales Value and Market Share of Remifentanil Made by Wuhan Humanwell in China, 2010-2014
Chart Sales Value and Market Share of Remifentanil Made by China National Pharmaceutical Industry Corporation Ltd in China, 2010-2014
Chart Sales Value and Market Share of Remifentanil Injection in China, 2010-2014
Chart Sales Volume and Market Share of Remifentanil Injection in China, 2010-2014
Chart Price of Remifentanil Made by Wuhan Humanwell in Some Chinese Cities in 2014
Chart Price of Remifentanil Made by China National Pharmaceutical Industry Corporation Ltd in Some Chinese Cities in 2014
